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Abstract
Background. Cardiovascular diseases (CVD) are associated with signiﬁcant morbidity and mortality, which is highest in Eastern
Europe including Estonia. Accumulating evidence suggests that life-style is associated with the development of CVD. The aim
of this study was to evaluate the informative power of common CVD-related markers under unhealthy conditions.
Subjects. Subjects (n = 51; mean age 45 years; 90% men) were recruited from a shelter for homeless people in Tallinn, Estonia,
and consisted of persons who constantly used alcohol or surrogates, smoked, and were in a bad physical condition (amputated
toes, necrotic ulcers, etc.).
Methods. Blood pressure, pulse rate, and waist circumference were measured, and body mass index (BMI) was calculated. The
following markers were measured in blood serum: total cholesterol (TChol), high-density lipoprotein cholesterol (HDL-Chol),
low-density lipoprotein cholesterol (LDL-Chol), plasma triglycerides (TG), apolipoproteins A-l (ApoA1) and B (ApoB),
lipoprotein(a) (Lp(a)), glycated hemoglobin (HbA1c), glucose (Gluc), high-sensitivity C-reactive protein (hsCRP), serum
carbohydrate-deﬁcient transferrin (CDT), gamma-glutamyltransferase (GGT), alanine aminotransferase (ALT), and aspar-
tate aminotransferase (AST). Except smoking, the anamnestic information considering eating habits, declared alcohol
consumption and medication intake were not included in the analysis due to the low credibility of self-reported data.
Results. More than half of the investigated patients had values of measured markers (hsCRP, TChol, LDL-Chol, TG, HbA1c,
ApoA1, ApoB, Lp(a), Gluc) within normal range. Surprisingly, 100% of subjects had HDL-Chol within endemic norm.
Conclusion. This study demonstrates that traditional markers, commonly used for prediction and diagnosis and treatment of
CVD, are not always applicable to homeless people, apparently due to their aberrant life-style.
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Introduction
Cardiovascular diseases (CVD) are one of the most
common clinical diagnoses in the world associated
with signiﬁcant morbidity and mortality, which is
highest in Eastern Europe including Estonia (1–3).
Also compared to international standards CVD read-
ings (risk factors) in Estonia are considered to be
higher (4,5).
A large body of experimental data and results from
cross-sectional studies indicate relationships between
CVD and total cholesterol (TChol), low-density
lipoprotein cholesterol (LDL-Chol), high-density
lipoprotein cholesterol (HDL-Chol), high-sensitivity
C-reactive protein (hsCRP), plasma triglycerides
(TG), and glucose (Gluc) tolerance (6–8). These
markers are automatically used to predict, diagnose,
and estimate the effectiveness of the CVD treatment
but still leave atherosclerosis-related diseases a major
challenge for scientists and cardiologists.
CVD is also considered to be the leading cause
of death among people who live unsalubrious
Correspondence: Margit Kaldmäe, Tallinn University, Institute of Mathematics and Natural Sciences, Tallinn, Estonia. E-mail: margitkaldmae@gmail.com
(Received 23 October 2010; accepted 29 April 2011)
ISSN 0300-9734 print/ISSN 2000-1967 online   2011 Informa Healthcare
DOI: 10.3109/03009734.2011.586737lives—homeless people (9,10). Undoubtedly, there
are factors which are inﬂuenced by people themselves,
e.g. unhealthy diet, physical inactivity, smoking, and
alcohol abuse (11), but at the same time controversial
connections have been demonstrated between life-
style and CVD risk factors (12–14).
Considering Estonia, homelessness became appar-
ent in the mid-1990s (15), but the data concerning
the number of homeless people are questionable. The
main reasons for becoming homeless in Estonia are
unemployment (85%) and/or alcoholism (60%) (16).
Most of homeless individuals have health problems,
but to keep their self-esteem the self-estimation of the
health condition is generally considered not bad (17).
In addition there are so far no studies carried out in
Estonia describing the health problems speciﬁct o
homeless people from a clinical point of view nor
their morbidity pattern and death rates.
Through investigating homeless people (persons
who live unsalubrious lives and are commonly
‘CVD-labeled’), the aim of this study was to assess
traditional CVD-related markers under unhealthy
conditions and to evaluate the actual informative
power of traditional risk markers as risk factors or
predictive markers for CVD.
Subjects
The study was approved by the Tallinn Medical
Research Ethics Committee, and written informed
consent was obtained from all of the participants
(46 males and 5 females, mean age 45 ± 12.5 years,
range 19–66 years). The recruitment and the proce-
dures (measurements, blood sample drawing, etc.)
took place in the District Shelter (situated in
Mustamäe Tallinn, Estonia) which is a place where
homeless people can stay for the night (when not
alcohol-intoxicated) but no systematic food provision,
medication, or any other services are rendered.
A homeless person was considered eligible for the
investigation if the following criteria were met:
. did not have permanent job
. did not have a regular income
. did not have a permanent home
. constantly used alcohol or surrogates
. did not have systematic (regular) eating habits
. was not engaged in regular physical activity.
The pre-recruitment procedure consisted of selec-
tion of the asocial contingent, based on the knowledge
of the shelter staff, who excluded those subjects (7 out
of 58) whom they met for the ﬁrst time or had seen
rarely. All the others (n = 51) were conﬁrmed as
eligible for the study, based on the above-mentioned
criteria. The selection, with assistance from the staff,
was followed by administration of a questionnaire
consisting of questions about education, work, life-
style (how many years of being homeless, eating
habits, smoking, drugs and alcohol consumption
(what and how much and for how long time), physical
activity (how long walks and how many hours out-
side)) and medical background (what illnesses and
what kind of treatment).
The self-reported data mentioned below, based
on participants’ answers, were not included (except
smoking—94% of participants conﬁrmed to be smo-
kers) in the analysis, due to low credibility, which was
found through many reasons: when speciﬁc informa-
tion met a contradiction with the data given by the
staff of the shelter, subjects denied or seemed to be
ashamed of their condition, were doubtful, did not
remember. Still the questionnaire gave us the extra
proof that they really were suitable for the study
considering our criteria.
The mean time of homeless status was approxi-
mately 4 years (3.6 ± 3.2 years). Even if the visible
physical condition spoke for itself, half of the partici-
pants denied or had a doubt of having any illness,
pain, or trauma. The other half of the participants
mostly claimed to have head, back, or leg traumas, but
pneumonia, arthritis, and asthma were also men-
tioned—25% used painkillers but the speciﬁc neces-
sary treatment or medication was still not obtained.
Also, for the purpose of ﬁnding out the participants’
medical background, a search of the medical data was
performed, which did not give any signiﬁcant results.
All participants conﬁrmed using alcohol or surro-
gates almost every day but did not give an overview
speciﬁcally what, in what amount, and for how long
periods of time they had been consuming.
Even though they all said that they had approxi-
mately two meals a day, it could not be counted as
systematic eating due to the fact that no food was
served at the shelter and also the information given by
the participants was doubtful (subjectivity arose as to
what is meant by the term ‘a meal’).
Contradictions were also found concerning infor-
mation about physical activity—participants claimed
to walk approximately 11 km (10.8 ± 7.1) a day,
but seeing their physical conditions this was largely
questionable.
Methods
Blood pressure (BP) and pulse rate were measured by
using a sphygmomanometer in a sitting position after
5 minutes of rest. In addition to weight and height
information, waist circumference was also registered
(measuring tape positioned mid-way between the top
of the hip-bone and the bottom of the rib-cage). Body
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divided by the square of the height in meters.
Blood sample collection and transport
All blood samples were obtained in a sitting position.
Guidelines, indicating the importance of fasting
from food before blood sampling, were given to
each participant before the testing period.
After an overnight fast, blood samples were col-
lected between 8.00 and 11.00 a.m., with standard
method from vena cubitalis using Vacutainer collec-
tion tubes (BD Vacutainer, Belliver Industrial Estate,
Plymouth; Becton, Dickinson and Co., UK) as fol-
lows: for Gluc determination with preservatives (ﬂuo-
ride oxalate); for glycated hemoglobin (HbA1c) with
ethylenediamine tetra-acetic acid (EDTA); for ala-
nine aminotransferase (ALT), aspartate aminotrans-
ferase (AST), gamma-glutamyltransferase (GGT),
hsCRP, CDT%, TChol, HDL-Chol, LDL-Chol,
and TG with clot activator without any more additives
or preservatives. Obtained samples were stored with-
out centrifugation and immediately transported at
room temperature to the laboratory. For apolipopro-
tein A-1 (ApoA1), apolipoprotein B (ApoB), and
lipoprotein(a) (Lp(a)) determinations whole blood
was collected in EDTA collection tubes and centri-
fuged within 1 hour to obtain plasma, which was
subsequently stored and transported on ice to the
laboratory.
Other laboratory samples, needed for serum sepa-
ration, were centrifuged and kept at +4C till
assessed. All determinations were performed by
following the standard procedures—on the day of
collection and within 12 hours.
Laboratory methods
Markers from blood serum were determined by using
different methods as follows. ALT and AST: reaction
rate assessment based on the conversion of NADH to
nicotinamide adenine dinucleotide (NAD); GGT:
kinetic method based on gamma-glutamyl group
transference to glycylglycine; Gluc:enzymatic refer-
ence method with hexokinase; hsCRP levels: particle-
enhanced immunoturbidimetric method; TChol:
cholesterol oxidase technique; HDL-Chol and
LDL-Chol: homogeneous enzymatic colorimetric
assay; TG: glycerol phosphate oxidase technique after
enzymatic cleavage of fatty acids. All of these deter-
minations were performed by reagents from Roche
(Roche Diagnostics, Mannheim, Germany) using
Roche Integra 800 analyzer.
Blood HbA1c was determined on Roche
Integra 400 analyzer using the particle-enhanced
immunoturbidimetric method. Final results were
expressed as percent HbA1c from total Hb according
to Diabetes Control and Complications Trial/
National Glycohemoglobin Standardization Program
(DCCT/NGSP) protocol. CDT measurement was
performed by latex-enhanced reagent from Dade
Behring using Behring BN analyzer (Siemens Health-
care Diagnostics, Deerﬁeld, USA).
Apolipoproteins ApoA1 and ApoB were analyzed
by using immunoturbidimetric assays and Lp(a)
by using particle-enhanced immunoturbidimetric
assays (Roche Diagnostics, Mannheim, Germany).
The intensity of the turbidity, proportional to the
concentration of antibody–antigen complexes, was
measured by the Roche Integra 400 analyzer.
Statistical analysis
Statistical analyses were performed using MS Excel
and Statistical package R. The characteristics of stud-
ied persons were presented as mean ± standard devi-
ation. 95% conﬁdence intervals of percentages were
evaluated with the exact binomial test in R.
Results
The comparison of data based on mean values versus
the reference values (RF) would not give an adequate
overview because the single extreme values would
signiﬁcantly skew the average results. Considering
this kind of subject distribution (how they ﬁtted
within the RF), percentage evaluation in addition to
average values was chosen.
During the examination most of the subjects were or
seemed to be in a bad physical condition—amputated
toes, necrotic ulcers, and other leg and back traumas.
Stillconsideringtheaimofthestudy(theschemewasnot
toanalyzetheirphysicalstateandmedicalcondition)the
true condition stayed unknown.
Data in brackets are represented as follows:
mean ± SD, range. For indices where reference values
are different between male (M) and female (F) study
participants the mean ± SD and range values are
indicated separately. As the exact values of Lp(a)
<0.08 were not known the median value instead of
the mean value was calculated.
Approximately a quarter of homeless subjects’ BMI
values met World Health Organization (WHO) criteria
for being overweight (RF ‡25). The rest of the partici-
pants (73%) had normal BMI value (22.9 ± 3.0, 17.8–
32.7kg/m
2).Alsothewaistcircumferencewasinnormal
rangeamong88.2%ofthestudypersons(M84.7±10.1,
64.0–110.0 cm; F 95.6 ± 10.5, 86.0–111.0 cm).
Evaluated on the basis of a mean systolic blood
pressure (SBP) RF ‡140 mmHg or a mean diastolic
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homeless subjects had high blood pressure (SBP
143.4 ± 24.9, 98.0–196.0 mmHg; DBP 82.3 ±
15.2, 52.0–118.0 mmHg).
Pulse rate was also high (>75 b/min) in 68.6% of the
persons studied (84.2 ± 14.3, 55.0–112.0 b/min)—
16% of them had tachycardia (>100 b/min).
More than half of the patients had hepatic toxiﬁca-
tion markers in the low or within the normal range:
GGT 68.6% (M 85.8 ± 147.9, 12.0–888.0 U/L; F
185.8 ± 268.8, 7.0–646.0 U/L), ALT 70.6% (M 45.7 ±
48.7, 9.0–249.0 U/L; F 38.8 ± 27.4, 12.0–75.0 U/L),
AST 51.0% (M 53.1 ± 45.8, 18.0–245.0 U/L; F 47.4 ±
27.2, 17.0–74.0 U/L); and also alcohol abuse marker,
CDT 56.9% (2.9 ± 2.1, 0.9–9.0%).
Also the markers which indicate high risk for CVD
were in the normal range among more than half of
patients: hsCRP 58.8% (12.1 ± 25.3, 0.3–129.0 mg/
L), TChol 64.7% (5.0 ± 1.4, 2.9–11.0 mmol/L),
LDL-Chol 68.6% (2.7 ± 1.1, 1.3–7.0 mmol/L), TG
88.2% (1.1 ± 0.6, 0.4–4.0 mmol/L), HbA1c 88.2%
(5.5 ± 0.3, 4.7–6.5%), ApoA1 84.3% (M 1.7 ± 0.3,
1.2–2.5 g/L; F 1.8 ± 0.8, 1.3–3.1 g/L), ApoB 92.2%
(M 0.7 ± 0.2, 0.4–1.3 g/L; F 1.1 ± 0.3, 0.6–1.5 g/L),
Lp(a) 56.9% (M 0.08, <0.08–0.9 g/L; F <0.08,0.08–
0.2 g/L), Gluc 60.8% (5.4 ± 0.9, 3.7–8.7 mmol/L).
When looking at the mean values of these markers,
only the hsCRP value was not within the endemic
norm. Surprisingly, 100% of the subjects had a nor-
mal HDL-Chol value(1.9 ± 0.7, 1.0–4.0 mmol/L).
A total of 90.2% of patients had low TChol/HDL
ratio (M 2.7 ± 0.8, 1.4–5.0; F 4.3 ± 1.7, 2.6–6.6), and
the LDL/HDL ratio was in the normal range among
72.5% of patients (M 1.5 ± 0.7, 0.4–3.6; F 2.7 ± 1.4,
1.3–4.5).
There were no subjects who had all measured
markers in the endemic norm.
Discussion
On the basis of a large body of evidence, TChol,
LDL-Chol, HDL-Chol, and TG are automatically
used in worldwide clinical practice as the ﬁrst selec-
tion to predict the risk of myocardial infarction (MI)
and also to estimate CVD treatment effectiveness.
Interestingly our study consisting of persons who
live unsalubrious life showed no signiﬁcant differ-
ences concerning average values of TChol, HDL-
Chol, LDL-Chol, and TG compared to reference
(endemic norm) values. Also, the percentage distri-
bution demonstrated that signiﬁcantly more than half
of persons studied had these markers in the normal
range (Table I).
Next, two ratios (TChol/HDL-Chol and LDL-
Chol/HDL-Chol) are used worldwide for acute MI
risk estimation in all ethnic groups, in both sexes and
all ages (19). In our study group these ratios were also
within the normal range (Table I).
ApoB is one of the principal proteins of the
atherogenic lipoprotein particles (LDL, intermediate-
density lipoprotein (IDL), very-low-density lipopro-
tein (VLDL)), and ApoA1 is a major protein
component of HDL. A number of clinical studies
demonstrate the association between low ApoA1
levels and an increased risk of MI and coronary artery
disease. Also an increased ApoB/ApoA1 ratio has a
role in clinical CVD development, including subclin-
ical atherosclerosis (20). In addition, according to a
large comprehensive study (INTERHEART study) the
ApoB/ApoA1 ratio was superior for the estimation
of the risk of acute myocardial infarction in all
ethnic groups, in both sexes and all ages (19). Our
study results showed a contradiction—no differences
between average values of ApoA1 and ApoB com-
pared to reference values were found. The percentage
distribution demonstrated that 84.3% of persons
had normal ApoA1, and 56.9% had normal ApoB
value.
The values related to TChol and its fractions have
been shown to be signiﬁcantly inﬂuenced by life-
style (physical activity, diet, etc.) and, through this,
related to a higher risk of CVD development (21,22).
Our study subjects, who were physically inactive and
on unhealthy diets, had predominantly normal aver-
age TChol and HDL-Chol values. Over half of the
subjects had normal LDL-Chol levels.
There is evidence that elevated levels of TG are
associated with increased risk of MI and ischemic
heart disease (23). Also it is known that systematic
aerobic training-load reduces TG levels (24). In our
study only six persons (11.8%) had elevated levels of
TG. This phenomenon cannot be explained by sys-
tematic activity because the persons under investiga-
tion were in very bad physical condition. At the same
time no relationships have been found between TG
and chronic alcohol consumption (25). The effect of
physical activity in our study is contradictory because,
for on the one hand it is relatively necessary to move
(walk) a lot to look for food from the trash bins, and
on the other hand the subjects’ very bad muscular and
skeletal system (amputated toes, necrotic ulcers, com-
plications after bone fractures, etc.) does not allow an
intensive physical load. One explanation for this
relatively low/normal TG level can be low-fat food
consumption (which has not been investigated in this
study).
CVD predictive markers (TChol, LDL-Chol,
HDL-Chol, and TG) used in everyday clinical prac-
tice did not have alarming concerns among homeless
people (more than half of the subjects had mentioned
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Characteristics No. % 95% CI
Blood pressure (mmHg)
Normal (SBP <120 and DBP <80) 8 15.7 (7.5–29.1)
Pre-hypertension (SBP 120–139 or DBP 80–89) 16 31.4 (19.5–46.0)
Stage 1 hypertension (SBP 140–159 or DBP 90–99) 15 29.4 (17.9–44.0)
Stage 2 hypertension (SBP ‡160 or DBP ‡100) 11 21.6 (11.8–35.7)
Not measured 1 2.0
Pulse rate (b/min)
Low (<70) 9 17.6 (8.9–31.4)
Normal (70–75) 6 11.8 (4.9–24.6)
High (>75) 35 68.6 (54.0–80.5)
Not measured 1 2.0
Waist circumference (cm)
Normal (M <102/F <88) 45 88.2 (75.4–95.1)
Overweight (M ‡102/F ‡88) 6 11.8 (4.9–24.6)
BMI (kg/m
2)
Underweight (<18.5) 1 2.0 (0.1–11.8)
Normal (18.5–24.9) 37 72.5 (58.0–83.7)
Overweight (>24.9) 13 25.5 (14.8–39.9)
ALT (U/L)
Normal (M <41/N <31) 36 70.6 (56.0–82.1)
High (M ‡41/N ‡31) 15 29.4 (17.9–44.0)
AST (U/L)
Normal (M <38/F <32) 26 51.0 (36.8–65.0)
High (M ‡38/F ‡32) 25 49.0 (35.0–63.2)
GGT (U/L)
Low (M <10/F <5) 0 0.0 –
Normal (M 10–66/F 5–39) 35 68.6 (54.0–80.5)
High (M >66/F >39) 16 31.4 (19.5–46.0)
CDT (%)
Low (<1.19) 6 11.8 (4.9–24.6)
Normal (1.19–2.47) 23 45.1 (31.4–59.5)
High (>2.47) 22 43.1 (29.6–57.7)
hsCRP (mg/L)
Normal (<5) 30 58.8 (44.2–72.1)
High (‡5) 21 41.2 (27.9–55.8)
TChol (mmol/L)
Normal (<5) 33 64.7 (50.0–77.2)
High (‡5) 18 35.3 (22.8–50.0)
HDL-Chol (mmol/L)
Normal (>1) 51 100.0 –
High (£1) 0 0.0 –
LDL-Chol (mmol/L)
Normal (<3) 35 68.6 (54.0–80.5)
High (‡3) 15 29.4 (17.9–44.0)
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some other risk factors (ApoB and ApoA1) have also a
certain limitation in their application.
What kind of risk markers/aspects should be taken
into account when this kind of population is under
investigation? It seems that inﬂammation-related
markers are more informative.
Among the subjects, the mean hs CRP value was
twice as high as the reference value (<5 mg/L), but
percentage evaluation showed that 58.8% of investi-
gated persons had normal values. This kind of
distribution was inﬂuenced by two persons whose
values were above100 mg/L. This kind of hsCRP
elevation is obviously caused by chronic inﬂamma-
tions due to what subjects suffer without getting any
cure or medication (legs wounds, pneumonia, der-
matitis, etc.).
The risk of cardiovascular morbidity and mortality
is greatly affected by cigarette smoking (26), and in
our study 94% of participants were smokers. Smoking
is claimed to be associated with a lower socio-
economic status (27), and the prevalence of nicotine
Table I. (Continued).
Characteristics No. % 95% CI
TG (mmol/L)
Normal (<1.7) 45 88.2 (75.4–95.1)
High (‡1.7) 6 11.8 (4.9–24.6)
HbA1c (%)
Low (<4.8) 1 2.0 (0.1–11.8)
Normal (4.8–5.9) 45 88.2 (75.4–95.1)
High (>5.9) 5 9.8 (3.7–22.2)
ApoA1 (g/L)
Low (M <1.0/F <1.1) 0 0.0 –
Normal (M 1.0–2.0/F 1.1–2.3) 43 84.3 (70.8–92.5)
High (M >2.0/F >2.3) 8 15.7 (7.5–29.1)
ApoB (g/L)
Low (M <0.7/F <0.6) 18 35.3 (22.8–50.0)
Normal (M 0.7–1.3/F 0.6–1.2) 29 56.9 (42.3–70.4)
High (M >1.3/F >1.2) 4 7.8 (2.5–19.7)
Lp(a) (g/L)
Normal (M <0.09/F <0.11) 29 56.9 (42.3–70.4)
High (M ‡0.09/N ‡0.11) 22 43.1 (29.6–57.7)
Gluc (mmol/L)
Low (<4.1) 3 5.9 (1.5–17.2)
Normal (4.1–5.9) 28 54.9 (40.5–68.6)
High (>5.9) 20 39.2 (26.2–53.9)
TChol/HDL ratio
Low (M <4.0/F <3.8) 46 90.2 (78.6–96.7)
Normal (M 4.0–23/F 3.8–11) 5 9.8 (3.3–21.4)
High (M >23/F >11) 0 0.0 –
LDL/HDL ratio
Low (M <1.1/F <1.6) 14 27.5 (15.9–41.7)
Normal (M 1.1–7.9/F 1.6–6.0) 37 72.5 (58.3–84.1)
High (M >7.9/F >6.0) 0 0.0 –
SBP = systolic blood pressure; DBP = diastolic blood pressure; BMI = body mass index; ALT = alanine aminotransferase; AST = aspartate
aminotransferase; GGT = gamma-glutamyltransferase; CDT =serum carbohydrate-deﬁcient transferring; hsCRP = high-sensitivity C-reactive
protein; TChol = total cholesterol; HDL-Chol = high-density lipoprotein cholesterol; LDL-Chol = low-density lipoprotein cholesterol;
TG = triglycerides; HbA1c = glycated hemoglobin; ApoA1 = apolipoprotein A-1; ApoB = apolipoprotein B; Lp(a) = lipoprotein(a);
Gluc = glucose.
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sers is extremely high (28) and is well documented
among homeless people (29–31). The measurement
of CDT is the only test approved by the Food and
Drug Administration (FDA) for determining heavy
alcohol use (32). Our results for CDT% showed
higher mean values of hepatic enzymes compared
to reference values. Surprisingly 45.1% of investi-
gated persons had normal values of CDT.
In the scientiﬁc literature, a faster resting pulse rate
has been shown to be associated with a higher risk of
developing hypertension and a greater incidence of
cardiovascular morbidity and mortality (26,33).In our
study 68.6% of investigated patients had elevated
pulse rates. This can be explained by sympathetic
over-activity, which is related to the following circum-
stances: smoking, alcohol intoxication, physical inac-
tivity, depression, and poor self-rated health (34).
Considering that in the shelter there was no sys-
tematic eating and no opportunity to cook, the BMI of
the investigated persons was normal compared to
the reference value. Only one person (c. 2% of the
research population) was underweight, and waist
circumference indices were all at normal range or
above. It can be concluded from this that the inves-
tigated group of homeless people did not suffer from
starvation. An explanation can be found in recent
research, which brought forth theinterconnection
between long-term alcohol consumption and height-
ened BMI (35). Unfortunately, accurate nutrition
research is methodically difﬁcult to conduct, and
also it was not the aim of the given research.
Persistent elevations in HbA1c level increase the
risk for the long-term vascular complications of dia-
betes such as coronary disease, heart attack, stroke,
heart failure, kidney failure, blindness, erectile dys-
function, neuropathy (loss of sensation, especially in
the feet), gangrene, and gastroparesis (slowed emp-
tying of the stomach). Elevated levels of HbA1c can
also be associated with disorders of glucose meta-
bolism, but among our investigated persons most
levels (88.2%) were within normal range.
Of course our study had some limitations. Because
experimentally it is unethical to recruit people to live
under unhealthy conditions, the selection of the study
contingent was made considering the objective of the
study—toexamineCVDmarkersinasocialgroupliving
unsalubriouslives.Thehomelesspeoplearenotanideal
group of choice for the study, because the credible
information of their prior life history(resultsof medical
examination and medical records, etc.) is missing, and
some results of the questionnaire were contradictory.
Based on life condition differentialities and social
status proﬁle between countries (climate, donations/
foundations for the homeless) our participants do not
constitute a representative sample of homeless people.
Also, they were in a bad physical condition, which
raises questions about the situation elsewhere. Based
on that, generalizations cannot be made.
An ideal structure of the research would also be to
assess the ‘amount’ of the unhealthy life-style choices,
i.e. the quantity of alcohol and drugs consumed,
smoking, physical capacity, etc. In this study, only
objective results of the physical and laboratory
analysis were used.
Originally it was planned to include a control-
group, but to ﬁnd people whose life-style was 100%
objectively proven and correspondent to that of home-
less people was difﬁcult (not controllable). Hence, the
outcome was compared with reference indices (anal-
ogously used in daily clinical practice). Conﬁdence
interval gives us the opportunity to generalize the
research results to the whole homeless contingent.
Conclusions
Our study demonstrates that traditional markers
used for prediction and diagnosis and treatment of
CVD may not demonstrate the same information
pattern among people who live unsalubrious lives—
homeless people. The fact is that CVD is still the
leading cause of death among homeless people (9,10),
and this kind of life-style cannot be understood to be
healthy for the cardiovascular system, but it certainly
throws light on the complexity and multifactorial
etiology of CVD development mechanisms and
may demonstrate the weak points of widely used
diagnostic markers.
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